• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Lyra Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 391K and EPS of USD -15.3982
04:00
Lyra Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 25K (forecast USD 154.25K), actual EPS USD -3.3849 (forecast USD -5.255)
04:00
Oct14
Hanbury Brown's Rating and Target Price for Lyra Therapeutics
11:22
Oct6
Hanbury Brown Rates Healthcare Sector Stocks
19:46
Aug13
Lyra Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 183K (forecast USD 181.25K), actual EPS USD -5.5144 (forecast USD -5.5266)
03:00
Lyra Therapeutics released FY2025 Semi-Annual Earnings on August 12 EST, with actual revenue of USD 366 K and EPS of USD -12.0001
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 25 K, Net Income -5.984 M, EPS -3.3849

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 183 K, Net Income -7.437 M, EPS -5.5144

May28
Reverse Stock Split(EST)

1-for-50 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
20.856
+208.61%
+13.832
SMX
292.495
+107.44%
+151.495
WHLR
5.520
+70.37%
+2.300
GURE
7.420
+56.54%
+2.680
DBRG
13.950
+43.52%
+4.260
IRBT
4.229
+39.57%
+1.199
TORO
5.471
+32.47%
+1.350
SPHL
4.400
+32.14%
+1.144
PRAX
248.700
+30.92%
+59.105
TDIC
0.3645
+29.81%
+0.084
View More